Travere Therapeutics, Inc.
TVTX
60 insider filings · Latest: Sep 15, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | May 5 8:53 PM | ROY BAYNES | Proposed Sale | 4,500 | $46.65 | $209.9K | — | View → |
| May 1, 2026 | May 4 8:27 PM | Roy D. BaynesDirector | Sale | 9,750 | $44.22 | $431.1K | 37,500(D) | View → |
| May 4, 2026 | May 4 8:04 PM | ELIZABETH REED | Proposed Sale | 20,000 | $45.00 | $900.0K | — | View → |
| May 4, 2026 | May 4 8:04 PM | JEFFREY MECKLER | Proposed Sale | 8,000 | $45.00 | $360.0K | — | View → |
| May 4, 2026 | May 4 8:03 PM | JULA INRIG | Proposed Sale | 20,000 | $45.00 | $900.0K | — | View → |
| May 1, 2026 | May 1 8:15 PM | ROY BAYNES | Proposed Sale | 9,750 | $44.22 | $431.1K | — | View → |
| Apr 22, 2026 | Apr 23 8:05 PM | William E. RoteChief Research Officer | Sale | 9,100 | $39.09 | $355.7K | 113,987(D) | View → |
| Apr 22, 2026 | Apr 22 2:36 PM | ROTE WILLIAM E. | Proposed Sale | 9,100 | $39.09 | $355.7K | — | View → |
| Apr 14, 2026 | Apr 16 8:05 PM | LYONS GARY ADirector | Sale | 8,000 | $41.07 | $328.6K | 57,500(D) | View → |
| Apr 14, 2026 | Apr 16 8:05 PM | Roy D. BaynesDirector | Sale | 32,750 | $41.29 | $1.4M | 37,500(D) | View → |
| Apr 14, 2026 | Apr 16 8:05 PM | Sandra CalvinSVP, CHIEF ACCOUNTING OFFICER | Sale | 21,977 | $41.07 | $902.6K | 42,353(D) | View → |
| Apr 14, 2026 | Apr 16 1:49 AM | Peter HeermaCHIEF COMMERCIAL OFFICER | Sale | 7,215 | $41.93 | $302.5K | 138,608(D) | View → |
| Apr 15, 2026 | Apr 16 1:48 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Sale | 64,000 | $41.09 | $2.6M | 432,886(D) | View → |
| Apr 15, 2026 | Apr 16 1:47 AM | Elizabeth E ReedChief Legal Officer and GC | Sale | 6,785 | $41.83 | $283.8K | 105,211(D) | View → |
| Apr 14, 2026 | Apr 16 1:47 AM | Elizabeth E ReedChief Legal Officer and GC | Sale | 44,715 | $41.21 | $1.8M | 111,996(D) | View → |
| Apr 15, 2026 | Apr 16 1:46 AM | Christopher R. ClineCHIEF FINANCIAL OFFICER | Sale | 1,014 | $42.61 | $43.2K | 116,899(D) | View → |
| Apr 14, 2026 | Apr 16 1:46 AM | Christopher R. ClineCHIEF FINANCIAL OFFICER | Sale | 7,248 | $41.93 | $303.9K | 117,913(D) | View → |
| Apr 13, 2026 | Apr 16 1:46 AM | Christopher R. ClineCHIEF FINANCIAL OFFICER | Sale | 65 | $28.85 | $1.9K | 125,161(D) | View → |
| Apr 15, 2026 | Apr 16 1:46 AM | Jula InrigCHIEF MEDICAL OFFICER | Sale | 1,018 | $42.61 | $43.4K | 111,473(D) | View → |
| Apr 14, 2026 | Apr 16 1:46 AM | Jula InrigCHIEF MEDICAL OFFICER | Sale | 7,215 | $41.93 | $302.5K | 112,491(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | Sep 18 1:35 AM | William E. RoteChief Research Officer | Option Exercise | 112,850 | $26.88 | 0(D) | View → |
| Sep 15, 2026 | Sep 18 1:35 AM | William E. RoteChief Research Officer | Option Exercise | 78,650 | $25.25 | 350(D) | View → |
| Sep 17, 2026 | Sep 18 1:35 AM | Peter HeermaEVP, CHIEF COMMERCIAL OFFICER | Option Exercise | 8,282 | $22.40 | 44,837(D) | View → |
| Sep 16, 2026 | Sep 18 1:35 AM | Peter HeermaEVP, CHIEF COMMERCIAL OFFICER | Option Exercise | 172,717 | $26.88 | 500(D) | View → |
| Sep 15, 2026 | Sep 18 1:35 AM | Peter HeermaEVP, CHIEF COMMERCIAL OFFICER | Option Exercise | 77,190 | $26.88 | 28,474(D) | View → |
| Sep 15, 2026 | Sep 18 1:33 AM | Jula InrigEVP, Head of R&D & CMO | Option Exercise | 32,395 | $8.93 | 43,605(D) | View → |
| Sep 15, 2026 | Sep 18 1:32 AM | Elizabeth E ReedChief Legal Officer and GC | Option Exercise | 37,500 | $15.46 | 0(D) | View → |
| Sep 17, 2026 | Sep 18 1:31 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 108,493 | $23.34 | 0(D) | View → |
| Sep 16, 2026 | Sep 18 1:31 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 195,841 | $23.34 | 108,493(D) | View → |
| Sep 15, 2026 | Sep 18 1:31 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 95,666 | $23.34 | 304,334(D) | View → |
| Sep 15, 2026 | Sep 18 1:30 AM | Christopher R. ClineCHIEF FINANCIAL OFFICER | Option Exercise | 20,000 | $17.44 | 0(D) | View → |
| Sep 15, 2026 | Sep 18 1:29 AM | Sandra CalvinSVP, CHIEF ACCOUNTING OFFICER | Option Exercise | 5,375 | $27.50 | 17,875(D) | View → |
| Sep 10, 2026 | Sep 11 8:05 PM | Meckler Jeffrey ADirector | Option Exercise | 20,000 | $26.52 | 0(D) | View → |
| Aug 18, 2026 | Aug 19 8:05 PM | LYONS GARY ADirector | Option Exercise | 5,000 | $17.44 | 0(D) | View → |
| Aug 17, 2026 | Aug 19 8:05 PM | LYONS GARY ADirector | Option Exercise | 5,000 | $17.44 | 5,000(D) | View → |
| Jun 12, 2026 | Jun 16 8:46 PM | Timothy CoughlinDirector | Option Exercise | 10,000 | $26.52 | 0(D) | View → |
| Jun 12, 2026 | Jun 16 8:42 PM | Roy D. BaynesDirector | Option Exercise | 4,500 | $21.38 | 0(D) | View → |
| May 19, 2026 | May 21 9:00 PM | Brinkley Ruth WilliamsDirector | Grant/Award | 12,000 | $42.26 | 12,000(D) | View → |
| May 19, 2026 | May 21 9:00 PM | Ron SquarerDirector | Grant/Award | 12,000 | $42.26 | 12,000(D) | View → |
| May 19, 2026 | May 21 9:00 PM | Sandra PooleDirector | Grant/Award | 12,000 | $42.26 | 12,000(D) | View → |
Page 1 of 4
Next →